Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
4
×
biotech
4
×
boston blog main
life sciences
national blog main
amgen
boston top stories
clinical trials
national top stories
new york blog main
new york top stories
alirocumab
deals
evolocumab
hepatitis b
inclisiran
new york
novartis
pcsk9 inhibitors
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
rna interference
san francisco blog main
the medicines company
vir biotechnology
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
beijing
bellus health
What
drug
new
4
×
medicines
brings
cholesterol
medco
acquire
adds
advantages
agreed
alliance
alnylam
areas
bar
based
billion
bio
biosciences
bio’s
brii
cash
company
compound
data
deal
disease
earlier
evidence
expect
fda
gamble
heart
hepatitis
infectious
lasting
launched
long
looms
lowering
market
Language
unset
Current search:
biotech
×
" alnylam pharmaceuticals "
×
new
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline